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Abstract
Purpose CAPE (caffeic acid phenethyl ester) is one of
the most valuable and investigated component of propolis
which is composed by honeybees. In the current study, we
aimed at examining apoptotic effects of CAPE on CCRF-
CEM leukemic cells and at determining the roles of
mitochondrial membrane potential (MMP) in cell death.
Methods Trypan blue and XTT methods were used to
evaluate the cytotoxicity. Apoptosis was examined by
ELISA-based oligonucleotide and acridine orange/ethi-
dium bromide dye techniques. Loss of mitochondrial
membrane potential was evaluated using JC-1 dye by flow
cytometric analysis and under fluorescent microscope.
Results We detected the time- and dose-dependent
increases in cytotoxic effect of CAPE on CCRF-CEM
cells. ELISA and acridine orange/ethidium bromide results
showed that apoptotic cell population increased signifi-
cantly in CCRF-CEM cells exposed to increasing concen-
trations of CAPE. On the other hand, there was significant
loss of MMP determined in response to CAPE in CCRF-
CEM cells.
Conclusion This in vitro data by being supported with
clinical data may open the way of the potential use of
CAPE for the treatment of leukemia.
Keywords CAPE  ALL  Apoptosis 
Mitochondrial membrane potential  Cytotoxicity
Introduction
Acute lymphoblastic leukemia (ALL) is a hematological
malignancy resulting from clonal proliferation of early
B- and T-lymphocyte progenitors. It is characterized by
increased accumulation of leukemic blast cells in bone
marrow and extramedullary sites. Although high rates of
hematological responses obtained from the current treat-
ment protocols in the vast majority of patients, the emer-
gence of resistance to applied anticancer agents decreases
the efficiency of treatment (Crazzolara and Bendall 1999).
Having poor outcomes, short-term survival rates, and
serious side effects in response to chemotherapeutic agents
in patients with ALL imposed basic science researchers
and clinicians to investigate novel anticancer agents
derived from the natural sources, such as plants, animals,
and sea products. Likewise, the numbers of studies inves-
tigating the anticancer potential of natural products have
been increasing significantly.
CAPE is a chemical and structural relative of flavanoids
and an active component of propolis. It has antiviral, anti-
inflammatory, immunomodulatory, and antiproliferative
effects in different conditions. Antiproliferative ability of
CAPE has been considered as a new anticancer treatment
modality and has been studied in many cancers and cell
lines both in vivo and in vitro (Crazzolara and Bendall
1999; Borrelli et al. 2002; Son and Lewis 2002; Lee et al.
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2000; Demestre et al. 2009). Several studies reported that
the antitumoral effect of CAPE was possibly related to the
alteration of redox potentials resulting in apoptosis, sup-
pression of lipid peroxidation, inhibition of ornithine
decarboxylase, and protein synthesis, and inhibition of
activation of nuclear factor kappa B (NF-jB; Li et al. 2000;
Berger et al. 1992; Rao et al. 1992; Michaluart et al. 1999;
Sud’ina et al. 1993; Fesen et al. 1994). Interestingly, it was
also shown that CAPE exerts apoptotic effect and sup-
presses the growth of transformed cells in a specific man-
ner (Chiao et al. 1995). However, the apoptotic effects of
CAPE on CCRF-CEM acute lymphoblastic leukemia cells
and, if so, the roles of mitochondrial membrane potential in
programmed cell death are not investigated previously.
Mitochondria have a central role in cellular functions in
both normal and cancerous cells. The impact of mitochon-
drial activities on cellular physiology is not only restricted to
ATP supply, but also to generate reactive oxygen species
(ROS), to regulate intracellular Ca2? homeostasis, and more
importantly to regulate apoptosis through cytochrome c
release (Gogvadze et al. 2008). Once the cytosolic effectors
of apoptosis are activated, loss of mitochondrial membrane
potential takes place, and cytochrome c and some other
proteins are released from the intermembrane space of
mitochondria to cytoplasm. This process activates caspases
and downstream targets resulting in apoptosis (Gogvadze
et al. 2006). Since the statues of mitochondria during the
glycolytic pathways are essential for the survival of cancer
cells, strategies targeting the mitochondria may provide an
important avenue for the treatment of various types of can-
cers. In fact, there are different chemotherapeutic agents that
can specifically alter the mitochondrial membrane potential
(Gogvadze et al. 2008; Wolvetang et al. 1994; Asoh et al.
1996; Schmidt-Mende et al. 2006; Neuzil et al. 2001, 2006,
2007; Yu et al. 2003).
In the present study, we aimed at investigating the
possible cytotoxic and apoptotic effects of CAPE on
CCRF-CEM leukemic cells and at clarifying the involve-
ment of the changes in mitochondrial membrane potential
in this apoptotic process.
Materials and methods
Cell line and chemicals
Human T-cell acute lymphoblastic leukemia cells (CCRF-
CEM) were obtained from ECACC (UK, No: 85112105).
CAPE was obtained from Sigma Chemical (LM, USA).
200 lM stock solution of CAPE was prepared and dis-
solved in dimethylsulfoxide (DMSO), and the final con-
centration of DMSO has never been more than 0.1% in the
experiments. Trypan blue dye was obtained from
Biological Industries (Israel). MitoProbe JC-1 Assay Kit
was obtained from Invitrogen (CA, USA). XTT Cell Pro-
liferation Assay was obtained from Roche Diagnostics
(Munchen, Germany). All the other chemicals and tissue
culture supplies were obtained from Sigma (Deisenhofen,
Germany) unless otherwise specified.
Evaluation of cytotoxicity
CCRF-CEM cell line grown in RPMI-1640 medium con-
taining 2 mM L-glutamine supplemented with 10% fetal
bovine serum (FBS) and 1% penicillin/streptomycin was
maintained at a density of 5 9 105 cells/ml in a standard
cell culture incubator at 37C, 100% relative humidity, and
5% CO2 atmosphere (Sahin et al. 2007). Prior to any
experiment, cells were split at 5 9 105 cells/ml in the
RPMI 1640 medium, and cell suspensions were aliquoted
into flasks for subsequent treatments. CAPE diluted in
RPMI 1640 was used in treatments of 1 nM, 10 nM,
100 nM, 1 lM, 10 lM, and 100 lM.
Cytotoxic assays and determination of IC50 (drug con-
centration that inhibits cell proliferation 50% when com-
pared to untreated controls) dose of CAPE in CCRF-CEM
cells were performed by using Trypan blue dye exclusion
and XTT assay as indicated in manufacturer’s instruction.
Cytotoxicity of CAPE by XTT-based cytotoxicity assay
was determined as follows:
Cells were seeded in 96-well tissue culture plates and
incubated for 24 h without drug. After addition of drug,
cells were incubated for 96 h, and cell viability was
assessed by using XTT-PMS mixture (XTT sodium salt;
[2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-2H-tetra-
zolium-5-carboxanilide inner salt], phenazine methosulfate
(N-methylphenazonium methyl sulfate salt)], as recom-
mended by supplier. Formazan formation was quantified
spectrophotometrically at 490 nM using a microplate
reader (Bio-Rad, Coda, Richmond, CA).
Evaluation of apoptosis
Apoptosis was evaluated using Cell Death Detection ELISA
assay (Roche Diagnostics, USA), and acridine orange/ethi-
dium bromide method under fluorescence microscope.
CAPE-induced apoptosis of CCRF-CEM cells was evalu-
ated by using Cell Death Detection ELISAPLUS assay
according to manufacturer’s instructions. Briefly, untreated
control and CAPE-treated cells were processed and analyzed
for cytotoxic histone-bound DNA fragments. CCRF-CEM
cells were exposed to 10 lM CAPE for 24, 48, 72, and
96 h. Changes in apoptosis rate were illustrated as the
apoptotic index increased over the untreated control
group. The absorbance, proportional to the degree of cell
viability, was determined after addition of 2,20-azino-di
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[3-ethylbenzthiozolin-sulfonate], as substrate at 15 min by
ELISA reader (Bio-Rad-Coda, Hercules, CA, USA) at
595 nm. The apoptosis level was calculated by the formula
As/Ao, where As represents the experimental sample absor-
bance, and Ao represents the average absorbance produced in
the assay using lysate from untreated cells. Apoptotic levels
of control cells at each time point were defined as 1.0.
In addition, apoptosis was also determined morpholog-
ically after staining with acridine orange/ethidium bromide
by fluorescence microscopy. Briefly, the cells were washed
with cold 19 PBS and adjusted to the cell density of
1 9 106 cells/ml in 19 PBS. Acridine orange and ethidium
bromide (1:1, v/v) were added to the cell suspension in
final concentrations of 100 lg/ml. After 30-min incubation
of the cells, the cellular morphology was evaluated by
fluorescence microscopy (Olympus, Japan). Apoptotic cells
were essentially characterized by nuclear condensation of
chromatin and/or nuclear fragmentation. Three hundred
cells were evaluated for apoptosis and/or necrosis for each
sample. When more than 50% of the pre-apoptotic plus
apoptotic to total cell ratio was positive, the result was
accepted positive for apoptosis.
Evaluation of mitochondrial membrane potential using
JC-1 by flow cytometry and florescence microscope
Loss of the mitochondrial membrane potential was detected
by using MitoProbeTM JC-1 Assay Kit by flow cytometry
(Invitrogen, OG, USA). JC-1 (5,50,6,60-tetrachloro-
1,10,3,30,tetraethylbenzimidazolocarbocyanine iodide) has
been widely used as a probe for cytofluorimetric analysis of
the mitochondrial membrane potential. In apoptotic cells,
JC-1 enters the cytoplasm as a monomer, emitting 527 nm
(green fluorescence) after excitation at 490 nm, but in
healthy cells it is taken up by the mitochondria, the lipo-
philic cationic dye accumulates within the negatively
charged, hyperpolarized mitochondrial matrix, and forms
JC-1 aggregates that emit at 590 nm (red fluorescence;
Cossarizza et al. 1993). Apoptotic cells were illustrated by
the increase in green/red ratio evaluated by either fluores-
cence microscope or flow cytometry (Salvioli et al. 1997;
Baran et al. 2007a; Swerts et al. 2004).
In order to assess the integrity of the mitochondrial
membrane, 1 9 106 CCRF-CEM cells treated with CAPE
were suspended in 1 ml of warm media. The cells were
labeled with 10 ll of JC-1 (200 lM) and incubated at 37C,
5% CO2 for 30 min. Excess amount of dye was removed by
washing with 19 PBS. Pelleted cells were resuspended in 19
PBS and analyzed via flow cytometer with excitation
wavelength of 480 nm, using appropriate emission filters for
Alexa Fluor 488 dye and R-phytoerythrin. The changes in
mitochondrial membrane potential in these cells were also
analyzed under fluorescence microscope.
Statistical analysis
Statistical analyses were conducted using SPSS statistical
package program. Non-linear regression analyses were used
for the relationships between different variables. Student’s
t test was used to compare the means. P values\0.05 were
considered statistically significant.
Results
Effects of CAPE on proliferation and viability
of human CCRF-CEM cells
We have shown antiproliferative effects of CAPE on
CCRF-CEM cells by both XTT cell proliferation and try-
pan blue dye exclusion assays. The results showed that
there were dose- and time-dependent decreases in cell
proliferation and viability when compared to untreated
controls.
There were 43, 49, 56, and 60% decreases in cell pro-
liferation in CCRF-CEM cells exposed to 10 lM CAPE for
24, 48, 72, and 96 h, respectively, compare to untreated
controls (Fig. 1). On the other hand, we have observed 10,
21, and 56% decreases in cell proliferation exposed to 0.1,
1, and 10 lM CAPE for 72 h.
We conducted the same set of experiments in order to
determine the cell viabilities by trypan blue assay. The
viability assay results were in agreement with cytotoxicity
analyses and revealed the dose- and time-dependent
decreases in viability of CCRF-CEM cells in response to
CAPE. As shown in Fig. 2, viable CCRF-CEM cell pop-
ulation were 65, 59, 13, and 3% in 10 lM CAPE-treated
and 24, 48, 72, and 96 h incubated cells, respectively, when
compared to untreated controls (Fig. 2). The application of
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Fig. 1 Effects of CAPE on the growth of CCRF-CEM cells. The
IC50 concentration of CAPE was calculated from cell proliferation
plots. The XTT assays were performed using triplicate samples in at
least two independent experiments. Statistical significance was
determined using Student’s t test, and (P \ 0.05) was considered
significant
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0.1, 1, and 10 lM CAPE for 72 h resulted in 85, 79, and
13% viability in CCRF-CEM cells.
Effect of CAPE treatment on early and late apoptosis
in CCRF-CEM cells
In order to examine apoptotic effects of CAPE on CCRF-
CEM cells, the cells were exposed to 10 lM CAPE for 24,
48, 72, and 96 h, and both early and late apoptosis were
evaluated by using Cell Death Detection ELISAPLUS assay.
In parallel with the previous data, the results revealed that
there were time-dependent increases in apoptotic cells.
About 5, 6, 29, and 39% of CCRF-CEM cell population
were in early apoptosis in response to 10 lM CAPE for 24,
48, 72, and 96 h, respectively. Late apoptotic cell popula-
tion in response to 10 lM CAPE in CCRF-CEM cells for
the same periods of time were determined to be 0, 21, 30,
and 25%, respectively (Fig. 3).
Changes in apoptotic index in response to CAPE
in CCRF-CEM cells
We evaluated apoptosis by Cell Death Detection ELISA
assay. As shown in Fig. 4, the results revealed that there
were 1.24-, 1.39-, 1.18-, 1.18-fold increases in apoptotic
index in CCRF-CEM cells treated with 10 lM CAPE for
24, 48, 72, and 96 h when compared to untreated controls
(Fig. 4).
Loss of mitochondrial membrane potential
in CCRF-CEM cells exposed to CAPE
Changes in mitochondrial membrane potential in CAPE-
applied CCRF-CEM cells were observed under fluores-
cence microscope and determined by flow cytometry.
Under fluorescence microscope, we observed that appli-
cation of 10 lM CAPE resulted in significant accumulation
of JC-1 dye in cytoplasm when compared to untreated
controls (Fig. 5). Treatment of CCRF-CEM cells with
10 lM CAPE resulted in cell death as detected by flow
cytometry. There were 29, 45, and 22% increases in death
CCRF-CEM cell population in response to 10 lM CAPE
for 24, 48, and 72 h, respectively, when compared to
untreated controls (Fig. 6).
Discussion
The numbers of chemotherapeutic agents extracted from
natural sources for the treatment of various types of cancers
have been increasing recently. Complications related to
chemical drugs forced scientists to develop novel treatment
agents for cancer. Drugs originating from plants are strong
potential agents not only since they have strong antitumor
properties but also because they do not have any harmful
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Fig. 2 Effects of CAPE on the viability of CCRF-CEM cells. Trypan
blue dye exclusion assays were performed using triplicate samples in
at least two independent experiments. Statistical significance was
determined using Student’s t test, and (P \ 0.05) was considered
significant
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Fig. 3 Percent changes in early and late apoptosis in CAPE-treated
CCRF-CEM cells. Statistical significance was determined using
Student’s t test, and P \ 0.05 was considered significant
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Fig. 4 Changes in apoptotic index in CCRF-CEM cells exposed to
CAAPE. Statistical significance was determined using Student’s t test,
and P \ 0.05 was considered significant
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effects on normal healthy cells (Cassileth et al. 2008;
Engdal et al. 2009).
Recently, caffeic acid phenethyl ester (CAPE), obtained
from honeybee propolis (Grunberger et al. 1998), has
attracted notice in that it represented antitumoral (Chiao
et al. 1995), anti-inflammatory (Michaluart et al. 1999;
Orban et al. 2000), antiviral (Fesen et al. 1994), antioxidant
(Bhimani et al. 1993), and anti-angiogenic (Liao et al.
1999) effects. Although the ability of CAPE to induce
apoptosis has been reported for various types of cancer,
very little is known about the effects of CAPE on human
CCRF-CEM cells (Michaluart et al. 1999; Fesen et al.
1994; Chiao et al. 1995; Grunberger et al. 1998; Orban
et al. 2000; Bhimani et al. 1993; Liao et al. 1999).
We conducted this study to examine whether CAPE has
cytotoxic and apoptotic effects on CCRF-CEM cells and, if
so, to investigate the mechanisms involved in cell death.
The results of XTT cell proliferation and trypan blue
viability assays revealed that CAPE has decreased prolif-
eration and viability of CCRF-CEM cells in a dose- and
time-dependent manner. On the other hand, in agreement
with these results, apoptosis assay results also showed a
dose- and time-dependent increases in apoptotic cell pop-
ulation in response to CAPE when compared to untreated
controls. Flow cytometry and fluorescence microscope
results revealed that CAPE induces apoptosis through
induction of mitochondrial dysfunction, as demonstrated
by the loss of mitochondrial membrane potential. It is very
well known in the literature that apoptosis can be triggered
by many internal and external stimuli, but mitochondria
(mitochondrial membrane potential) are a common inter-
section point for all apoptotic pathways. As the numbers of
permeability transition pores are increased which results in
decreases in mitochondrial depolarization and release of
calcium, caspase are activated and apoptosis is triggered.
Thus, many internal and external stress generating factors
result in the loss of mitochondrial membrane potential.
Induction of apoptosis through loss of mitochondrial
membrane potential was previously shown in K562 and
Meg-01 chronic myeloid leukemia cells in response to
imatinib, in acute lymphoblastic cells in response to res-
veratrol, in T-lymphoma cells in response to genistein, in
HL60 cells in response to Hoechst 33342, and in acute
lymphoblastic leukemia cells in response to resveratrol
(Baran et al. 2007b, c; Zunino and Storms 2006; Baxa et al.
2005; Chen et al. 2004).
In agreement with our results, it was recently shown by
two different groups that CAPE induces apoptosis in
human U937 myeloid leukemia cells through mitochon-
drial pathway but not through death receptors or
ER-mediated apoptosis (Do¨rrie et al. 2001). Chen et al.
(2008) have shown that CAPE induced a time-dependent
increase in apoptotic cell population through mitochondrial
dysfunction in human BcPC-3 pancreatic cancer cells. The
same group has also showed the loss of mitochondrial
membrane potential to about half of the untreated level in
response to CAPE only after 6 h in HL60 cells (Chen et al.
2001). It was reported by several groups that CAPE
inhibited cell growth and proliferation and triggered
apoptosis in SW480 and HCT116 colorectal cancer cells,
ME180 cervical cancer cells, C6 glioma cells, and MCF-7
Fig. 5 Micropicture of CCRF-CEM cells treated with CAPE
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breast cancer cell (He et al. 2006; Wang et al. 2005; Hung
et al. 2003; Lee et al. 2003; Watabe et al. 2004; Burke et al.
1995). On other hand, it was shown by Chung and his
coworkers that besides inhibition of cell proliferation,
CAPE also has inhibitory effects on invasion and metas-
tasis through suppression of MMP-9 enzyme and down-
regulation of expression of NF-KB (Chung et al. 2004).
CAPE has also been shown to have cell cycle arrest and
DNA, RNA, and protein inhibition ability on HL60 cells
(Chen et al. 1996). Interestingly, several studies showed
that CAPE has no cytotoxic and apoptotic effects on nor-
mal healthy cells (Lee et al. 2003). It was shown in 2005
that CAPE application increased sensitivity of CT26
colorectal adenocarcinoma cells to ionizing radiation in
BALB/c mouse while showed no cytotoxic effects on bone
marrow, kidney, and liver (Chen et al. 2005). These studies
suggest that CAPE has cytotoxic effects only on malignant
cells.
In conclusion, we have demonstrated for the first time
that human CCRF-CEM acute lymphoblastic leukemia
cells exposed to increasing concentrations of CAPE
undergo apoptosis in a time- and dose-dependent manner.
While the complete mechanism is not clear, we have
shown by this study that CAPE-induced apoptosis at least
involves loss of mitochondrial membrane potential which
activates caspases. Taken together, these results may sug-
gest that active component of propolis, CAPE, may have
chemotherapeutic potential for the treatment of human
acute lymphoblastic leukemia by inducing apoptosis.
However, clinical outcomes of CAPE application remain to
be examined before its use in clinics.
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